GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Equity-to-Asset

Cereno Scientific AB (OSTO:CRNO B) Equity-to-Asset : 0.44 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cereno Scientific AB's Total Stockholders Equity for the quarter that ended in Mar. 2025 was kr167.01 Mil. Cereno Scientific AB's Total Assets for the quarter that ended in Mar. 2025 was kr378.22 Mil.

The historical rank and industry rank for Cereno Scientific AB's Equity-to-Asset or its related term are showing as below:

OSTO:CRNO B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.42   Med: 0.9   Max: 0.96
Current: 0.44

During the past 10 years, the highest Equity to Asset Ratio of Cereno Scientific AB was 0.96. The lowest was 0.42. And the median was 0.90.

OSTO:CRNO B's Equity-to-Asset is ranked worse than
70.24% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs OSTO:CRNO B: 0.44

Cereno Scientific AB Equity-to-Asset Historical Data

The historical data trend for Cereno Scientific AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Equity-to-Asset Chart

Cereno Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 0.94 0.93 0.76 0.46

Cereno Scientific AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.76 0.67 0.46 0.44

Competitive Comparison of Cereno Scientific AB's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cereno Scientific AB's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's Equity-to-Asset falls into.


;
;

Cereno Scientific AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cereno Scientific AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=191.926/413.772
=

Cereno Scientific AB's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=167.006/378.22
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cereno Scientific AB  (OSTO:CRNO B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cereno Scientific AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cereno Scientific AB Business Description

Traded in Other Exchanges
Address
BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines